Zacks Small Cap Issues Negative Forecast for ENSC Earnings
Ensysce Biosciences, Inc. (NASDAQ:ENSC – Free Report) – Investment analysts at Zacks Small Cap reduced their Q1 2025 EPS estimates for shares of Ensysce Biosciences in a research report issued to clients and investors on Tuesday, March 11th. Zacks Small Cap analyst B. Sorensen now anticipates that the company will post earnings per share of […]
